Maulik Nanavaty

CIK: 0001529708

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RANI

Rani Therapeutics Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

RANI
Rani Therapeutics Holdings, Inc.
May 28, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
50K shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 16, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
101.3K shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 16, 2024
Award(A)
Stock Option (Right to Buy)
Direct
101.3K shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 16, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
15.4K shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 16, 2024
Award(A)
Stock Option (Right to Buy)
Direct
15.4K shares-

		Type	Shares	Price		Ownership
May 28, 2025	RANI Rani Therapeutics Holdings, Inc.	Award(A) Director Stock Option (Right to Buy)	50,000	-	-	Direct
Dec 16, 2024	RANI Rani Therapeutics Holdings, Inc.	Disposition(D) Stock Option (Right to Buy)	101,276	-	-	Direct
Dec 16, 2024	RANI Rani Therapeutics Holdings, Inc.	Award(A) Stock Option (Right to Buy)	101,276	-	-	Direct
Dec 16, 2024	RANI Rani Therapeutics Holdings, Inc.	Disposition(D) Stock Option (Right to Buy)	15,423	-	-	Direct
Dec 16, 2024	RANI Rani Therapeutics Holdings, Inc.	Award(A) Stock Option (Right to Buy)	15,423	-	-	Direct

1-5 of 5 transactions

About Nanavaty Maulik

Nanavaty Maulik (SEC CIK 0001529708) files insider reports with the SEC as Director of Rani Therapeutics Holdings, Inc. (RANI).

Signal8 holds 2 ownership filings by Nanavaty Maulik, all Form 4s, filed between Dec 17, 2024 and May 30, 2025. Those filings report 5 transactions, from Dec 16, 2024 to May 28, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Nanavaty Maulik's filings is in SAN JOSE, CA.

Recent filings by Nanavaty Maulik

May 28, 2025: Grant or award of RANI derivative securities (Form 4, code A).
Dec 16, 2024: Disposition to issuer transaction of RANI derivative securities (Form 4, code D).
Dec 16, 2024: Grant or award of RANI derivative securities (Form 4, code A).
Dec 16, 2024: Disposition to issuer transaction of RANI derivative securities (Form 4, code D).
Dec 16, 2024: Grant or award of RANI derivative securities (Form 4, code A).

Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)

Imran Talat, Chief Executive Officer
Javadi Alireza, Chief Technical Officer
Gilson Michelle, Director
IMRAN MIR A, Director
Maestas Nicholas, Chief Financial Officer
McKinley Kate, Chief Business Officer

How to read Form 4 transaction codes